RXO, Inc.

▲ Bull Case

• ◆Freight-cycle inflection plus operating leverage drives explosive earnings growth. A return to mid-cycle freight conditions by 2027–2028 would push net revenue per load from ~$180 (trough) toward $260–275, simultaneously expanding load volume from cycle lows; with 60–70% incremental EBITDA margins on net revenue growth, the trough-to-recovery EBITDA bridge could move from current ~$130M to $400–525M — yielding 200%+ EBITDA expansion and supporting a $30+ stock price.
• ◆Coyote integration creates a structurally larger, more efficient combined entity at re-rated multiple. The $70M+ raised synergy target plus the migration of Coyote's carrier and coverage operations onto RXO Connect establishes a meaningfully bigger and more profitable platform than legacy RXO alone — and if execution continues 'ahead of schedule' as management characterized Q3 2025 progress, the combined entity should trade at a premium to standalone RXO multiples.
• ◆Convoy's exit plus Coyote consolidation has reshaped the competitive landscape favorably. Two major mid-tier freight brokerage competitors have been removed from the public landscape (Convoy via shutdown October 2023; Coyote via RXO acquisition September 2024) — concentrating market share opportunity for the remaining big-three (CHRW, RXO, JBHT) and reducing competitive intensity for the next cycle expansion phase.

▼ Bear Case

• ◆The cycle-recovery thesis has already missed multiple expected timelines; further delay would crush the leveraged story. The prep-file-era expectation of cycle recovery in 2024–2025 has empirically failed — Q1 2026 EBITDA of $6M is well below where the recovery thesis predicted. If recovery delays into 2028+, FCF stays compressed, leverage stays elevated, and the equity value discounts a longer waiting period at high WACC; the market needs $525M of mid-cycle EBITDA to justify $25.58 — that requires both cycle and Coyote to deliver, with limited room for slippage.
• ◆Post-Coyote, RXO's balance sheet is more levered at an unfavorable rate environment. Net debt rose to ~$1.5B post-acquisition financing, pushing interest expense to ~$135M annually in 2026 (vs. ~$55–70M pre-Coyote baseline) — and consuming ~80% of trough EBITDA, leaving negligible FCF for deleveraging. Refinancing pressure intensifies if cycle doesn't recover before 2028 maturities approach.
• ◆Stock at $25.58 trades at premium to sell-side targets, fair value, and historical multiples. Average sell-side 1-year target is $20.50 (20% below spot); probability-weighted intrinsic value is ~$16; FY2030 normalized 11x EV/EBITDA bears ~$19 per share — all three triangulate to substantial downside from current price. The market may be early-pricing a recovery that takes longer than two years to materialize.

“Consensus view (sell-side): Cycle recovery is coming but timing remains uncertain (most analysts have 12–18-month targets in the $18–22 range averaging $20.50). EBITDA trajectory FY2026 ~$130M → FY2027 ~$200M is the median expectation. Multiples assume a re-rating from cycle-trough discount once volume inflection is visible. The debate splits on three critical questions: (1) Cycle timing—is the trough finally inflecting (Q2 2026 guide suggests yes), or is this a head-fake before further weakness? (2) Coyote synergies—is the $70M+ target achievable on schedule, or will integration friction extend timeline? (3) Multiple justification—should RXO trade at parity with CHRW (~12–14x normalized) or at meaningful discount (~9–10x) given higher leverage and weaker historical execution track record? Variant view (this analysis): The market price is pricing optimism on all three debates simultaneously — that's why spot exceeds average sell-side targets. The probability-weighted view incorporates more realistic distribution of outcomes (15% bull / 45% base / 30% bear / 10% severe), yielding ~$16 fair value. The market is implicitly assigning ~50%+ probability to the bull case.”

• ◆Cycle inflection confirmed (DAT load-to-truck ratio >3.0x sustained) — medium probability, H2 2026–2027
• ◆Coyote synergies fully realized ($70M+ annualized) — medium-high probability, end-2026
• ◆Q2/Q3 2026 EBITDA beats on forward guidance — medium probability, Aug/Nov 2026 earnings
• ◆Managed transportation contract wins (>$50M revenue) — medium probability, ongoing
• ◆Refinancing of term loan at favorable rate — medium probability, 2027–2028
• ◆ND/EBITDA de-leverage below 4.5x — medium probability, 2027–2028
• ◆RXO Connect auto-match rate >65% formally disclosed — medium probability, 2027–2028

• ◆Extended freight trough with cycle delay into 2028+ (Very High) — invalidates recovery thesis, extends losses, crushes leverage story
• ◆Macro recession reduces freight demand (Very High) — amplifies cyclical headwind and structural freight broker headwinds
• ◆Coyote integration friction and extended restructuring (Medium-High) — delays $70M+ synergy realization and reduces run-rate EBITDA
• ◆Covenant breach risk if EBITDA remains at trough (High) — equity catastrophically impaired if leverage exceeds ~6.5–7.5x ND/EBITDA limits
• ◆Disintermediation by Amazon Freight or Uber (Medium long-term) — structural threat to freight broker model and market share
• ◆Carrier market power compression in loose freight markets (Medium) — margin compression and lower incremental EBITDA returns
• ◆Floating-rate debt exposure in elevated rate environment (Medium) — higher interest expense reduces FCF if rates stay elevated through 2027